TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 61 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,688 | +264.5% | 363 | +266.7% | 0.00% | – |
| Q2 2023 | $3,755 | +56.0% | 99 | 0.0% | 0.00% | – |
| Q1 2023 | $2,407 | -19.8% | 99 | +12.5% | 0.00% | – |
| Q4 2022 | $3,000 | +50.0% | 88 | +22.2% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 72 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 72 | -19.1% | 0.00% | – |
| Q1 2022 | $4,000 | +100.0% | 89 | +102.3% | 0.00% | – |
| Q4 2021 | $2,000 | -80.0% | 44 | -72.5% | 0.00% | – |
| Q3 2021 | $10,000 | 0.0% | 160 | +17.6% | 0.00% | – |
| Q2 2021 | $10,000 | 0.0% | 136 | +3.8% | 0.00% | – |
| Q1 2021 | $10,000 | +233.3% | 131 | +274.3% | 0.00% | – |
| Q4 2020 | $3,000 | -76.9% | 35 | -84.8% | 0.00% | – |
| Q3 2020 | $13,000 | -13.3% | 231 | +4.5% | 0.00% | – |
| Q2 2020 | $15,000 | +7.1% | 221 | 0.0% | 0.00% | – |
| Q1 2020 | $14,000 | – | 221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |